Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

Laia Reverté, Elena Yeregui, Montserrat Olona et al.|Clinical and Translational Medicine|2022

Cited by 16